Home
Resources
Publications
Enhancement of Sensitivity Using Hybrid Stimulus for the Diagnosis of Prostate Cancer Based on Polydiacetylene (PDA) Supramolecules

Enhancement of Sensitivity Using Hybrid Stimulus for the Diagnosis of Prostate Cancer Based on Polydiacetylene (PDA) Supramolecules

Il Kyoung Kwon, Jun Pyo Kim, Sang Jun Sim

Biosens Bioelectron. 2010 Dec 15;26(4):1548-53.

PMID: 20732801

Abstract:

In this study, hybrid stimulus was initially introduced to improve the sensitivity of PDA vesicle chip for detection of prostate-specific antigen-α1-antichymotrypsin (PSA-ACT) complex. The strategy of hybrid stimulus on PDA vesicle chip offers the amplification method of fluorescent signal which combines a primary response by the immune reaction of antigen-antibody and a secondary response by the mechanical pressure of pAb-conjugated magnetic beads. As the primary response result on PDA vesicle chip, the PSA-ACT complex in PBS buffer was detected at 10 ng/mL. However, this detection sensitivity was insufficient for diagnosis of prostate cancer because the normal human PSA concentration is less than 4.0 ng/mL. To solve this problem, polyclonal PSA antibody-conjugated magnetic beads were used as an amplifying agent after primary immunoresponse. As a result, the PSA-ACT complex concentrations (as low as 0.1 ng/mL) could be detected in the PBS buffer sample. Therefore, this result can be applied to various fields, such as the detection of cells, proteins, and DNA for sensitive and specific biosensing based on PDA supramolecules.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
IAR42414845	Prostate Specific Antigen-α1-Antichymotrypsin Complex human			Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: